# Completion Audit

Objective: create a research + product + architecture spec for Toddler Language Atlas from `PROJECT_CONTEXT.md`, without implementing the app.

## Evidence Inspected

- Project context: `/Users/ts/Documents/toddler-language-atlas/PROJECT_CONTEXT.md`
- Subagent outputs:
  - child language development research
  - skill-map / curriculum architecture
  - toddler game/product design
  - software/data architecture
- External sources:
  - CDC 2, 3, 4, and 5 year milestones
  - NIDCD speech and language milestones
  - ASHA communication milestones and speech sound guidance
  - Zero to Three early literacy guidance
  - NAEYC phonological awareness guidance
  - NICHD/National Early Literacy Panel early literacy predictors
  - HealthyChildren/AAP digital media guidance
- Produced artifacts:
  - `/Users/ts/Documents/toddler-language-atlas/SPEC.md`
  - `/Users/ts/Documents/toddler-language-atlas/SKILL_SCHEMA.yaml`

## Requirement Check

| Requirement | Evidence | Status |
|---|---|---|
| Product vision | `SPEC.md` section 1 | Complete |
| Ages 2-5 language-skill DAG | `SPEC.md` sections 3-4 | Complete |
| Initial nodes for current likely frontier | `SPEC.md` section 5 and `SKILL_SCHEMA.yaml` seed nodes | Complete |
| JSON/YAML schema | `SKILL_SCHEMA.yaml` | Complete |
| Toddler mastery model | `SPEC.md` section 6, `SKILL_SCHEMA.yaml` mastery defaults | Complete |
| Adaptive frontier-selection algorithm | `SPEC.md` section 7, `SKILL_SCHEMA.yaml` recommendation config | Complete |
| 8-12 game/activity types | `SPEC.md` section 8 | Complete |
| Parent workflow | `SPEC.md` section 9 | Complete |
| First playable MVP scope | `SPEC.md` section 12 | Complete |
| Roadmap into later literacy/reading | `SPEC.md` section 14 | Complete |
| Learner progression simulations | `SPEC.md` section 13, `SKILL_SCHEMA.yaml` simulation profiles | Complete |
| Developmentally appropriate constraints | `SPEC.md` sections 1, 2, 6, 8, 12 | Complete |
| Evidence-backed vs assumptions vs open questions | `SPEC.md` section 2 | Complete |
| Credible sources cited | `SPEC.md` section 15 | Complete |
| No implementation | Only markdown/YAML spec artifacts were created | Complete |

## Residual Risk

- This is an evidence-informed product spec, not clinical advice or a validated curriculum.
- Source guidance varies by child, language background, and context.
- The schema is concrete enough for MVP planning, but implementation will need validation code and tests to enforce graph rules.
